表紙
市場調查報告書
商品編碼
1023344

D2C遺傳基因檢驗的全球市場 (2021-2031年):市場預測 (各產品類型、銷售管道)、15個國家的製圖、競爭情形

Global Direct-to-Consumer Genetic Testing Market: Focus on Direct-to-Consumer Genetic Testing Market by Product Type, Distribution Channel, 15 Countries Mapping, and Competitive Landscape - Analysis and Forecast, 2021-2031

出版日期: | 出版商: BIS Research Inc. | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球D2C遺傳基因檢驗的市場規模在預測期間內預計以17.30%的年複合成長率發展,2031年成長到66億450萬美元的規模。

分子生物學領域的研究資金增加,世界水準的個人化醫療的認知度、接受度提高等要素促進該市場的成長。同時,基因資料的保護,倫理性、社會問題,法規標準的缺乏等課題預計成為抑製市場成長的要素。

本報告提供全球D2C遺傳基因檢驗的市場調查,市場定義和概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,市場規模的變化、預測,技術、通路、產品類型、地區等各種區分的明細,競爭環境,主要企業簡介等彙整資訊。

第1章 產品定義

第2章 市場範圍

第3章 調查手法

第4章 市場概要

  • 產品定義
  • 經營模式
  • 未來的可能性
  • COVID-19的影響

第5章 法律制度

第6章 市場動態

  • 影響分析
  • 阻礙市場要素
  • 市場機會
  • 主要趨勢
  • 主要策略、展開
  • 市場佔有率分析

第7章 市場分析、預測:各技術

  • 標的分析
  • 一鹼多型(SNP)
  • 全基因序列(WGS)

第8章 市場分析、預測:各銷售管道

  • 線上
  • OTC

第9章 市場分析、預測:各產品類型

  • 祖先
    • 家譜
    • 血緣
  • 健康和保健
    • 預測檢驗
    • 基因帶原檢測
    • 藥理基因學試驗
  • 娛樂

第10章 市場分析、預測:各地區、主要國家

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 其他地區

第11章 企業簡介

  • 23andme Inc.
  • 24Genetics
  • Ancestry.com LLC
  • Atlas Biomed
  • Color Genomics
  • DNAfit
  • Gene by Gene
  • Chengdu Twenty-Three Rubik's Cube Biotechnology Co., Ltd.
  • EasyDNA
  • Mapmygenome
  • MyHeritage Ltd.
  • Laboratory Corporation of America Holdings
  • Myriad Genetics, Inc.
  • Konica Minolta, Inc.
  • XCODE Life
目錄
Product Code: BHP0315SB

“Global Direct-to-Consumer Genetic Testing Market to Reach $6,604.5 Million by 2031.”

Market Report Coverage - Direct-to-Consumer Genetic Testing

Market Segmentation

  • Product Type- Ancestry, Health and Wellness, and Entertainment
  • Technology - Targeted Analysis, Single Nucleotide Polymorphisms (SNPs), and Whole Genome Sequencing (WGS)
  • Distribution Channel- Online Channel and Over-the-Counter Channel

Regional Segmentation

  • North America - U.S., Canada
  • Europe- Germany, France, Italy, U.K., Spain, and Rest-of-Europe
  • Asia-Pacific - China, Japan, Australia, India, and South Korea
  • Latin America - Brazil, Mexico, and Rest-of-the-Latin America
  • Rest-of-the-World

Market Growth Drivers

  • Growing Number of Direct-to-Consumer Genetic Tests
  • Decreasing Cost of Sequencing
  • Increasing Research Funding in the Field of Molecular Biology
  • Increase in Awareness and Acceptance of Personalized Medicines on a Global Level

Market Challenges

  • Genomic Data Protection
  • Uncertain Regulatory Standards for Direct-to-Consumer Genetic Tests
  • Ethical and Social Issues

Market Opportunities

  • Massive Scope for Adoption of Genomic-Based Medicine in Emerging Nations
  • Capitalizing on the High Prevalence of Genetic Disorders
  • Growth in Emerging Nations

Key Companies Profiled

23andme Inc., 24Genetics, Ancestry.com LLC, Atlas Biomed, Color Genomics, DNAfit, Gene by Gene, Chengdu Twenty-Three Rubik's Cube Biotechnology Co., Ltd., EasyDNA, Mapmygenome, MyHeritage Ltd., Laboratory Corporation of America Holdings, Myriad Genetics, Inc., Konica Minolta, Inc., XCODE Life.

Key Questions Answered in this Report:

  • What are the major market drivers, challenges, and opportunities in the global direct-to-consumer genetic testing market?
  • What are the key development strategies implemented by the major players in order to sustain in the competitive market?
  • Which is the dominant product type developed by the leading and emerging of direct-to-consumer genetic testing market?
  • What are the key technologies that have been used by leading players in the global market for the development of consumer genetic tests?
  • How is each segment of the market expected to grow during the forecast period 2021-2031? The segments are:
    • product type
    • technology
    • distribution channel
    • geography
  • Which companies are anticipated to be highly disruptive in the future, and why?
  • What are the regulations for the development of direct-to-consumer genetic testing?

Market Overview

BIS Research healthcare experts have found the direct-to-consumer genetic testing market to be one of the growing markets, which is predicted to grow at a CAGR of 17.30% during the forecast period, 2021-2031. The direct-to-consumer genetic testing market's growth has been primarily attributed to the major drivers in this market, such as growing number of direct-to-consumer genetic testing, increasing research funding in the field of molecular biology, and increase in awareness and acceptance of personalized medicine on a global level. However, genomic data protection, ethical and social issues, and lack of regulatory standards are some of the factors expected to restrain the market growth.

Decreased cost and time required for genetic sequencing has increased the acceptance of DTC genetic testing among the consumers. DTC genetic testing companies offer these genetic tests to their consumers through online channels and over-the-counter (OTC) channels, which has made these tests easily accessible to consumers around the globe.

The market is favored by the increased research activities based on next-generation sequencing-based technologies. The technology has been segmented into targeted analysis, whole genome sequencing, and single nucleotide polymorphisms. The whole genome sequencing segment is expected to grow at the highest CAGR of 17.37% during the forecast period 2021-2031. This increase is mainly attributed to a large number of research and development being conducted due to the COVID-19 pandemic and regulatory approvals gained by key companies for genetic health risks-based tests.

Within the research report, the market is segmented on the basis of product type, technology, distribution channel, and region. Each segment covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Competitive Landscape

With the increasing consumer awareness and intense market penetration, companies such as 23andme, Inc., Ancestry.com, LLC, and Color Genomics have become pioneers and significant competitors in this market.

Other key players in the market are 24Genetics, Easy DNA, DNAfit, and My Heritage Ltd., among others.

The increased demand for complex and custom sequencing techniques, rising genetic testing services, and growing research to treat and diagnose genetic and infectious diseases have opened opportunities for companies to expand their product portfolios, increase automation facilitation, and develop novel consumer genetics solutions by adopting different strategic approaches. Some of the strategies followed by the contributors are new product launches and enhancements, agreements, collaborations, partnerships, acquisitions, and expansions. For instance, in 2020, Eastern Biotech & Life Sciences launched Genoplan, which offers advanced genetic tests analyzing hundreds of medical, health, and well-being categories.

As the industry is new and currently unregulated, skepticism arises among government organizations and customers about the validity of the test results. Despite the good acceptance in some countries, few countries still require genetic counseling to be part of their mainstream genetic tests. Companies can collaborate with physicians and genetic counselors to analyze the genetic test results or to pre-test counseling to the customers. This could also lead to opening a new distribution channel of the market, therefore increasing the sales of these genetic tests.

The direct-to-consumer genetic testing market has been widely accepted in North America and some regions of Europe, such as the U.K. as well as in few parts of Asia-Pacific. Companies exploring regions such as the U.A.E, China, South Korea, and EU5 can open many business opportunities. Establishes players as well as new entrants should be focusing on shaping the regulatory landscape for the different countries and paving the way for entry into the regulated market, thus gaining the confidence of the consumers. Expanding globally will result in the explosion of the market.

Furthermore, established key players in the market should work with governments to organize education and awareness programs for consumers and genetic counselors for effective interpretation of results, providing consumers a sense of empowerment, which will certainly help the growth of the market. Due to the limited awareness among consumers and training among primary physicians or genetic counselors, there are high chances of misinterpretation of results and inappropriate test utilization. Professional support to the consumers will help the consumers to understand better about the outcomes and transform the reach of healthcare to the consumers.

Table of Contents

1 Product Definition

  • 1.1 Inclusion and Exclusion

2 Market Scope

  • 2.1 Scope of Work
  • 2.2 Key Questions Answered in the Report

3 Research Methodology

  • 3.1 Global Direct-to-Consumer Genetic Testing Market: Research Methodology
  • 3.2 Primary Data Sources
  • 3.3 Secondary Data Sources
  • 3.4 Market Estimation Model
  • 3.5 Criteria for Company Profiling

4 Market Overview

  • 4.1 Product Definition
    • 4.1.1 Ancestry Tests
    • 4.1.2 Health and Wellness Test
    • 4.1.3 Entertainment Test
  • 4.2 Direct-to-Consumer Genetic Testing Business Model
    • 4.2.1 One-to-One
    • 4.2.2 One-to-Many
  • 4.3 Future Potential
  • 4.4 COVID-19 Impact: Global Direct-to-Consumer Genetic Testing Market

5 Global Direct-to-Consumer Genetic Testing Market Regulatory Landscape

  • 5.1 Legal Requirements and Regulations
  • 5.2 Regulation in North America
    • 5.2.1 U.S.
    • 5.2.2 Canada
  • 5.3 Regulation in Europe
    • 5.3.1 Germany
    • 5.3.2 France
    • 5.3.3 U.K.
    • 5.3.4 Italy
    • 5.3.5 Spain
  • 5.4 Regulation in APAC
    • 5.4.1 China
    • 5.4.2 Regulation in Japan
    • 5.4.3 Australia
    • 5.4.4 South-Korea

6 Market Dynamics

  • 6.1 Impact Analysis
    • 6.1.1 Growing Number of Direct-to-Consumer Genetic Tests
    • 6.1.2 Increase in Awareness and Acceptance of Personalized Medicines on a Global Level
    • 6.1.3 Decreasing Cost of Sequencing
    • 6.1.4 Increasing Research Funding in the Field of Molecular Biology
  • 6.2 Market Restraints
    • 6.2.1 Genomic Data Protection
    • 6.2.2 Uncertain Regulatory Standards for Direct-to-Consumer Genetic Tests
    • 6.2.3 Ethical and Social Issues
  • 6.3 Market Opportunity
    • 6.3.1 Massive Scope for Adoption of Genomic-Based Medicine in Emerging Nations
    • 6.3.2 Capitalizing on the High Prevalence of Genetic Disorders
    • 6.3.3 Growth in Emerging Nations
  • 6.4 Key Trends
    • 6.4.1 Curiosity Among Consumers
    • 6.4.2 Increasing Public Awareness
    • 6.4.3 Mushrooming Direct-to-Consumer Genetic Testing Services Market
    • 6.4.4 Need for Precision Medicine
    • 6.4.5 Hassle-Free Model
  • 6.5 Key Strategies and Developments
    • 6.5.1 Synergistic Activities
    • 6.5.2 Approvals
    • 6.5.3 Product Launches and Expansions
    • 6.5.4 Acquisitions and Mergers
    • 6.5.5 Funding
  • 6.6 Market Share Analysis

7 Global Direct-to-Consumer Genetic Testing Market (by Technology), $Million, 2020-2031

  • 7.1 Overview
  • 7.2 Targeted Analysis
  • 7.3 Single Nucleotide Polymorphism (SNPs)
  • 7.4 Whole Genome Sequencing (WGS)

8 Global Direct to Consumer Genetic Testing Market (by Distribution Channel), $Million, 2020-2031

  • 8.1 Overview
    • 8.1.1 Online Channel
    • 8.1.2 Over-the-Counter (OTC) Channel

9 Global Direct-to-Consumer Genetic Testing Market (by Product Type), $Million, 2020-2031

  • 9.1 Ancestry
    • 9.1.1 Genealogy
    • 9.1.2 Relationship
  • 9.2 Health and Wellness
    • 9.2.1 Predictive Tests
    • 9.2.2 Carrier Tests
    • 9.2.3 Pharmacogenomics Tests
  • 9.3 Entertainment

10 Global Direct-to-Consumer Genetic Testing Market (by Region), $Million, 2020-2031

  • 10.1 North America
    • 10.1.1 U.S.
    • 10.1.2 Canada
  • 10.2 Europe
    • 10.2.1 Germany
    • 10.2.2 France
    • 10.2.3 U.K.
    • 10.2.4 Italy
    • 10.2.5 Spain
  • 10.3 Asia-Pacific (APAC)
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Australia
  • 10.4 Latin America
    • 10.4.1 Brazil
    • 10.4.2 Mexico
    • 10.4.3 Rest-of-Latin America (RoLA)
  • 10.5 Rest-of-the-World

11 Company Profiles

  • 11.1 Overview
  • 11.2 23andme Inc.
    • 11.2.1 Company Overview
    • 11.2.2 Role of 23andme Inc. in the Global Direct-to-Consumer Genetic Testing Market
    • 11.2.3 Financials
    • 11.2.4 Key Insights About Financial Health of the Company
    • 11.2.5 SWOT Analysis
  • 11.3 24Genetics
    • 11.3.1 Company Overview
    • 11.3.2 Role of 24Genetics in the Global Direct-to-Consumer Genetic Testing Market
    • 11.3.3 SWOT Analysis
  • 11.4 Ancestry.com LLC
    • 11.4.1 Company Overview
    • 11.4.2 Role of Ancestry.com LLC in the Global Direct-to-Consumer Genetic Testing Market
    • 11.4.3 SWOT Analysis
  • 11.5 Atlas Biomed
    • 11.5.1 Company Overview
    • 11.5.2 Role of Atlas Biomed in the Global Direct-to-Consumer Genetic Testing Market
    • 11.5.3 SWOT Analysis
  • 11.6 Color Genomics
    • 11.6.1 Company Overview
    • 11.6.2 Role of Color Genomics in the Global Direct-to-Consumer Genetic Testing Market
    • 11.6.3 SWOT Analysis
  • 11.7 DNAfit
    • 11.7.1 Company Overview
    • 11.7.2 Role of DNAfit in the Global Direct-to-Consumer Genetic Testing Market
    • 11.7.3 SWOT Analysis
  • 11.8 Gene by Gene
    • 11.8.1 Company Overview
    • 11.8.2 Role of Gene by Gene in the Global Direct-to-Consumer Genetic Testing Market
    • 11.8.3 SWOT Analysis
  • 11.9 Chengdu Twenty-Three Rubik's Cube Biotechnology Co., Ltd.
    • 11.9.1 Company Overview
    • 11.9.2 Role of Twenty-Three Rubik's Cube Biotechnology Co., Ltd. in the Global Direct-to-Consumer Genetic Testing Market
    • 11.9.3 SWOT Analysis
  • 11.1 EasyDNA
    • 11.10.1 Company Overview
    • 11.10.2 Role of EasyDNA in the Global Direct-to-Consumer Genetic Testing Market
    • 11.10.3 SWOT Analysis
  • 11.11 Mapmygenome
    • 11.11.1 Company Overview:
    • 11.11.2 Role of Mapmygenome India Ltd. in the Global Direct-to-Consumer Genetic Testing Market
    • 11.11.3 SWOT Analysis
  • 11.12 MyHeritage Ltd.
    • 11.12.1 Company Overview
    • 11.12.2 Role of MyHeritage Ltd. In the Global Direct-to-Consumer Genetic Testing Market
    • 11.12.3 SWOT Analysis
  • 11.13 Laboratory Corporation of America Holdings
    • 11.13.1 Company Overview
    • 11.13.2 Role of Laboratory Corporation of America Holdings in the Global Direct-to-Consumer Genetic Testing Market
    • 11.13.3 Financials
    • 11.13.4 SWOT Analysis
  • 11.14 Myriad Genetics, Inc.
    • 11.14.1 Company Overview
    • 11.14.2 Role of Myriad Genetics, Inc. in the Global Direct-to-Consumer Genetic Testing Market
    • 11.14.3 Financials
    • 11.14.4 Key Insights About Financial Health of the Company
    • 11.14.5 SWOT Analysis
  • 11.15 Konica Minolta, Inc.
    • 11.15.1 Company Overview
    • 11.15.2 Role of Konica Minolta, Inc. in the Global Direct-to-Consumer Genetic Testing Market
    • 11.15.3 Financials
    • 11.15.4 Key Insights About Financial Health of the Company
    • 11.15.5 SWOT Analysis
  • 11.16 XCODE Life
    • 11.16.1 Company Overview
    • 11.16.2 Role of XCODE Life in the Global Direct-to-Consumer Genetic Testing Market
    • 11.16.3 SWOT Analysis

List of Tables

  • Table 5.1: List of FDA-Approved Tests
  • Table 6.1: Likert Scale
  • Table 6.2: Impact Analysis of Market Drivers
  • Table 6.3: Impact Analysis of Market Restraints

List of Figures

  • Figure 1: Cumulative Number of Tested Conditions and Associated Genes for Genetic Testing, 2012-2019
  • Figure 2: Impact Analysis on the Global Direct-to-Consumer Genetic Testing Market
  • Figure 3: Global Direct-to-Consumer Genetic Testing Market (by Product Type), $Million, 2020 Vs. 2031
  • Figure 4: Global Direct-to-Consumer Genetic Testing Market (by Distribution Channel), $Million, 2020 Vs. 2031
  • Figure 5: Global Direct-to-Consumer Genetic Testing Market (by Technology), $Million, 2020 Vs. 2031
  • Figure 6: Global Direct-to-Consumer Genetic Testing Market Snapshot (by Region), $Million, 2020 and 2031
  • Figure 2.1: Global Direct-to-Consumer Genetic Testing Market Segmentation
  • Figure 3.1: Global Direct-to-Consumer Genetic Testing Market Methodology
  • Figure 4.1: Direct-to-Consumer Genetic Testing Market Workflow
  • Figure 4.2: Global Direct-to-Consumer Genetic Testing Market: COVID-19 Impact
  • Figure 6.1: Number of Direct-to-Consumer Genetic Tests Conducted, 2016-2021
  • Figure 6.2: Decreasing Cost and Increasing Output (Terabyte of Genome Sequencing, 2009-2025
  • Figure 6.3: Key Genetic Disorder Prevalence in the U.S., 2012-2019
  • Figure 6.4: Share of Key Strategies and Developments, January 2017 - June 2021
  • Figure 6.5: Synergistic Activities Share (by Company), January 2017-June 2021
  • Figure 6.6: Approvals Share (by Company), January 2017-March 2021
  • Figure 6.7: Product Launches, Enhancements, and Expansions Share (by Company), January 2017 - June 2021
  • Figure 6.8: Acquisitions and Mergers Share (by Company), January 2017 - June 2021
  • Figure 6.9: Funding Share (by Company), January 2017- June 2021
  • Figure 6.10: Market Share Analysis for Global Direct-to-Consumer Genetic Testing Market, 2020
  • Figure 7.1: Global Direct-to-Consumer Genetic Testing Market (by Technology), $Million, 2020-2031
  • Figure 7.2: Global Direct-to-Consumer Genetic Testing (DTC-GT) Market (Targeted Analysis), $Million, 2020-2031
  • Figure 7.3: Global Direct-to-Consumer Genetic Testing (DTC-GT) Market (Single Nucleotide Polymorphism), $Million, 2020-2031
  • Figure 7.4: Global Direct-to-Consumer Genetic Testing (DTC-GT) Market (Whole Genome Sequencing), $Million, 2020-2031
  • Figure 8.1: Global Direct-to-Consumer Genetic Testing Market (by Distribution Channel), $Million, 2020-2031
  • Figure 8.2: Global Direct-to-Consumer Genetic Testing (DT C-GT) Market (Online Channel), $Million, 2020-2031
  • Figure 8.3: Global Direct-to-Consumer Genetic Testing Market (OTC Channel), $Million, 2020-2031
  • Figure 9.1: Global Direct-to-Consumer Genetic Testing Market (by Product Type), $Million, 2020-2031
  • Figure 9.2: Global Direct-to-Consumer Genetic Testing Market (DTC-GT) Market (Ancestry), $Million, 2020-2031
  • Figure 9.3: Global Direct-to-Consumer Genetic Testing Market (Genealogy), $Million, 2020-2031
  • Figure 9.4: Global Direct-to-Consumer Genetic Testing Market (Relationship), $Million, 2020-2031
  • Figure 9.5: Global Direct-to-Consumer Genetic Testing Market (Health and Wellness), $Million, 2020-2031
  • Figure 9.6: Global Direct-to-Consumer Genetic Testing Market (Predictive Tests), $Million, 2020-2031
  • Figure 9.7: Global Direct-to-Consumer Genetic Testing Market (Carrier Tests), $Million, 2020-2031
  • Figure 9.8: Global Direct-to-Consumer Genetic Testing Market (Pharmacogenomics Tests), $Million, 2020-2031
  • Figure 9.9: Global Direct-to-Consumer Genetic Testing Market (Entertainment), $Million, 2020-2031
  • Figure 10.1: Global Direct-to-Consumer Genetic Testing Market (by Region), $Million, 2020-2031
  • Figure 10.2: North America Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
  • Figure 10.3: North America Direct-to-Consumer Genetic Testing Market (by Country), $Million, 2020-2031
  • Figure 10.4: U.S. Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
  • Figure 10.5: Canada Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
  • Figure 10.6: Europe Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
  • Figure 10.7: Europe Direct-to-Consumer Genetic Testing Market (by Country), $Million, 2020-2031
  • Figure 10.8: Germany Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
  • Figure 10.9: France Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
  • Figure 10.10: U.K. Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
  • Figure 10.11: Italy Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
  • Figure 10.12: Spain Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
  • Figure 10.13: Asia-Pacific (APAC) Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
  • Figure 10.14: China Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
  • Figure 10.15: Japan Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
  • Figure 10.16: India Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
  • Figure 10.17: South Korea Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
  • Figure 10.18: Australia Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
  • Figure 10.19: Latin America Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
  • Figure 10.20: Latin America Direct-to-Consumer Genetic Testing Market (by Country), $Million, 2020-2031
  • Figure 10.21: Brazil Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
  • Figure 10.22: Mexico Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
  • Figure 10.23: RoLA Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
  • Figure 10.24: Rest-of-the-World Direct-to-Consumer Genetic Testing Market, $Million, 2020-2031
  • Figure 11.1: Share of Key Company Profiles
  • Figure 11.2: 23andMe, Inc.: Overall Product Portfolio
  • Figure 11.3: 23andMe: Overall Financials, 2019-2020
  • Figure 11.4: 23andMe: Revenue (by Segment), 2019-2020
  • Figure 11.5: 23andMe: R&D Expenditure, 2019-2020
  • Figure 11.6: 23andme Inc.: SWOT Analysis
  • Figure 11.7: 24Genetics.: Overall Product Portfolio
  • Figure 11.8: 24Genetics: SWOT Analysis
  • Figure 11.9: Ancestry.com LLC.: Overall Product Portfolio
  • Figure 11.10: Ancestry.com LLC: SWOT Analysis
  • Figure 11.11: Atlas Biomed: Overall Product Portfolio
  • Figure 11.12: Atlas Biomed: SWOT Analysis
  • Figure 11.13: Color Genomics: Overall Product Portfolio
  • Figure 11.14: Color Genomics: SWOT Analysis
  • Figure 11.15: DNAfit: Overall Product Offerings
  • Figure 11.16: DNAfit: SWOT Analysis
  • Figure 11.17: Gene by Gene: Overall Product Portfolio
  • Figure 11.18: Gene by Gene: SWOT Analysis
  • Figure 11.19: Twenty-Three Rubik's Cube Biotechnology Co., Ltd.: Overall Product Portfolio
  • Figure 11.20: Chengdu Twenty-Three Rubik's Cube Biotechnology Co., Ltd.: SWOT Analysis
  • Figure 11.21: EasyDNA: Overall Product Portfolio
  • Figure 11.22: EasyDNA: SWOT Analysis
  • Figure 11.23: Mapmygenome India Ltd.: Overall Product Portfolio
  • Figure 11.24: Mapmygenome: SWOT Analysis
  • Figure 11.25: MyHeritage Ltd: Overall Product Portfolio
  • Figure 11.26: MyHeritage Ltd.: SWOT Analysis
  • Figure 11.27: Laboratory Corporation of America Holdings: Portfolio
  • Figure 11.28: Laboratory Corporation of America Holdings: Overall Financials, 2018-2020
  • Figure 11.29: Laboratory Corporation of America Holdings: Revenue (by Segment), 2018-2020
  • Figure 11.30: Laboratory Corporation of America Holdings: Revenue (by Region), 2020
  • Figure 11.31: Laboratory Corporation of America Holdings: SWOT Analysis
  • Figure 11.32: Myriad Genetics, Inc.: Product Portfolio
  • Figure 11.33: Myriad Genetics, Inc.: Overall Financials, 2018-2020
  • Figure 11.34: Myriad Genetics, Inc.: Revenue (by Business Segment), 2018-2020
  • Figure 11.35: Myriad Genetics, Inc.: R&D Expenditure, 2018-2020
  • Figure 11.36: Myriad Genetics, Inc.: SWOT Analysis
  • Figure 11.37: Konica Minolta, Inc: Product portfolio
  • Figure 11.38: Konica Minolta, Inc.: Overall Financials, 2017-2019
  • Figure 11.39: Konica Minolta, Inc.: Revenue (by Business Segment), 2017-2019
  • Figure 11.40: Konica Minolta, Inc.: Regional revenue, 2017-2019
  • Figure 11.41: Konica Minolta, Inc.: R&D Expenditure, 2017-2019
  • Figure 11.42: Konica Minolta, Inc: SWOT Analysis
  • Figure 11.43: XCODE Life: Overall Product Portfolio
  • Figure 11.44: XCODE Life: SWOT Analysis